T-Cell Responses before and after the Fifth Consecutive Acellular Pertussis Vaccination in 4-Year-Old Dutch Children
Open Access
- 26 September 2012
- journal article
- Published by American Society for Microbiology in Clinical and Vaccine Immunology
- Vol. 19 (11) , 1879-1886
Abstract
Immunization with acellular pertussis vaccine (aP) induces higher specific antibody levels and fewer adverse reactions than does immunization with the whole-cell vaccine (wP). However, antibody levels in infants induced by both types of pertussis vaccines wane already after 1 year. Therefore, long-term T-cell responses upon vaccination might play a role in protection against pertussis. In a cross-sectional study (ISRCTN65428640), we investigated T-helper (Th) cell immune responses in wP- or aP-vaccinated children before and after an aP low-dose or high-dose preschool booster at 4 years of age in The Netherlands. T cells were stimulated with pertussis vaccine antigens. The numbers of gamma interferon-producing cells and Th1, Th2, Th17, and interleukin-10 (IL-10) cytokine concentrations were determined. In addition, pertussis-specific IgE levels were measured in plasma. Children being vaccinated with aP vaccinations at 2, 3, 4, and 11 months of age still showed higher pertussis-specific T-cell responses at 4 years of age than did wP-vaccinated children. These T-cell responses failed to show a typical increase in cytokine production after a fifth aP vaccination but remained high after a low-dose booster and seemed to decline even after a high-dose booster. Importantly, elevated IgE levels were induced after this booster vaccination. In contrast, wP-vaccinated children had only low prebooster T-cell responses, and these children showed a clear postbooster T-cell memory response even after a low-dose booster vaccine. Four high-dose aP vaccinations in infancy induce high T-cell responses still present even 3 years after vaccination and enhanced IgE responses after preschool booster vaccination. Therefore, studies of changes in vaccine dosage, timing of pertussis (booster) vaccinations, and the possible association with local side effects are necessary.Keywords
This publication has 38 references indexed in Scilit:
- Pertussis Circulation Has Increased T-Cell Immunity during Childhood More than a Second Acellular Booster Vaccination in Dutch Children 9 Years of AgePLOS ONE, 2012
- BCG Vaccination Induces Different Cytokine Profiles Following Infant BCG Vaccination in the UK and MalawiThe Journal of Infectious Diseases, 2011
- Different IgG-subclass distributions after whole-cell and acellular pertussis infant primary vaccinations in healthy and pertussis infected childrenVaccine, 2011
- Impact of infant and preschool pertussis vaccinations on memory B-cell responses in children at 4 years of ageVaccine, 2011
- Rationale for pertussis booster vaccination throughout life in EuropeThe Lancet Infectious Diseases, 2011
- Comparison of the tolerability of an acellular pertussis-containing vaccine given as the fifth booster dose in differently primed childrenVaccine, 2011
- Seroprevalence of Pertussis in the Netherlands: Evidence for Increased Circulation of Bordetella pertussisPLOS ONE, 2010
- Differences of humoral and cellular immune response to an acellular pertussis booster in adolescents with a whole cell or acellular primary vaccinationVaccine, 2008
- Immune Responses and Antibody Decay after Immunization of Adolescents and Adults with an Acellular Pertussis Vaccine: The APERT StudyThe Journal of Infectious Diseases, 2004
- TH1/TH2 immune response profiles differ between atopic children in eastern and western GermanyJournal of Allergy and Clinical Immunology, 2002